CancerLinQ?

Our own Dr. Robert Miller weighs in in this white paper published by Clinical Research Data Sharing Alliance. We are proud to serve in this important effort to make the best and most ethical use of data to further research and treatment options to benefit cancer care for all. #RWD #realworlddata #clinicaltrials

Join us as Louis Culot, General Manager of CancerLinQ at ConcertAI, takes us on a journey through the groundbreaking ways CancerLinQ is transforming cancer care. By harnessing the power of data, CancerLinQ is making it easier for healthcare providers to navigate the complexities of cancer care. Deployed across the U.S. in academic centers, community clinics, and large health systems, this innovative platform is enhancing treatment decisions and improving patient outcomes. With tools like the SmartLinQ portal, integrated seamlessly with electronic medical records, doctors receive crucial alerts right when they need them most! This means more informed decisions at critical points in a patient's treatment journey. Technologies like RxLink and TriaLinQ empower healthcare professionals to identify patients who are eligible for new therapies and clinical trials—addressing a pressing issue: only 7% of patients currently access these vital opportunities. By analyzing disparities in cancer care, CancerLinQ is committed to driving concordant care, ensuring that every patient receives the best possible treatment tailored to their unique needs. Let's support a future where cancer care is not just a battle, but a journey informed by data and compassion! Learn more about CancerLinQ: https://hubs.ly/Q02Md1b80 #CancerCare #DataDriven #HealthInnovation #ClinicalTrials #PatientOutcomes #ConcertAI #FightCancer #HealthcareTransformation

Learn how CancerLinQ, a ConcertAI initiative, is revolutionizing cancer care by utilizing electronic health data to improve quality and drive discovery. In this video, see how the SmartLinQ application integrates oncology practice data from multiple sites to provide decision support at the point of care. Clinics rely on quality programs like COPI and ASCO certified to maintain high standards. Stay ahead of the curve with SmartLinQ's actionable patient feature, updated regularly to help doctors track new therapies, biomarkers, and patient eligibility in real time. And now, with the addition of TriaLinQ, part of ConcertAI's Digital Trial Solutions, practices can easily screen patients for clinical trials and seamlessly transition new sites with minimal IT integration. View our video showcase to learn more: https://hubs.ly/Q02Lm8yz0 #CancerCare #DigitalHealth #Innovation #SmartLinQ

Our Patient Match capabilities are designed to help streamline your work and drive impactful results. To give you a closer look at what TriaLinQ can offer, we've put together a comprehensive factsheet. This factsheet dives deep into the features, benefits, and potential impact that TriaLinQ can have on your clinical trial processes. Request to download the factsheet: https://hubs.ly/Q02KMN6r0 #Innovation #Research #TriaLinQ #PatientMatch #ClinicalTrials

Today is World Lung Cancer Day, a day dedicated to raising awareness about the impact of lung cancer. In honor of this important day, we want to highlight a recent study done by AstraZeneca and the Cleveland Clinic using the CancerLinQ Discovery database. The researchers investigated the prevalence of EGFR mutations in early-stage non-small-cell lung cancer (NSCLC) patients and the treatments they received in routine clinical practice. EGFR mutations can impact treatment decisions, especially for patients with stage IB–IIIA NSCLC. Findings show that only 21.6% of patients underwent EGFR mutation testing, highlighting the importance of testing for personalized treatment plans. Learn more: https://hubs.ly/Q02JKNzN0 #LungCancerResearch #EGFRmutations #PersonalizedMedicine #WLCD24 #WorldLungCancerDay

Are you an oncologist feeling overwhelmed by the ever-increasing amount of information needed to care for people with cancer? RxLinQ? is a precision medicine feature that identifies patients who may be eligible for newly approved, molecularly-targeted therapies, reducing information overload and providing essential clinical decision support. Ideal for oncologists and cancer care teams, RxLinQ matches patients to FDA labels using data already collected by CancerLinQ. Stay on top of the latest advancements in cancer care with RxLinQ! Request factsheet: https://hubs.ly/Q02G-bvK0 #PrecisionMedicine #CancerCare #RxLinQ #SmartLinQ #Oncology #ClinicalDecisionSupport

Are you tired of your practice's valuable data going to waste? With SmartLinQ?, you can finally harness the power of your real-world data to make positive changes in cancer care delivery. This digital solution offers interactive dashboards, reports, decision support tools, and more by analyzing your EHR data seamlessly. Whether you're a clinician, administrator, quality team member, or researcher, SmartLinQ is the ultimate platform to drive improvements in care quality, operational efficiency, research operations, and more. Say goodbye to letting your data gather virtual dust and unlock its full potential with SmartLinQ. The future of data-driven cancer care is here, and it's time to start tapping into your greatest data asset. Don't miss out on the opportunity to elevate every aspect of cancer care delivery. Request your copy of the full factsheet on SmartLinQ's robust capabilities: https://hubs.ly/Q02GmWVt0 #SmartLinQ #DataDrivenCare #CancerCareDelivery #HealthcareInnovation

Are you looking for a streamlined solution to accelerate your oncology practice's clinical trial activities? Look no further than TriaLinQ, powered by ConcertAI's Digital Trial Solutions. This single, secure, integrated platform simplifies complex trial operations, ensures compliance, and improves data collection accuracy with pre-populated fields that reduce manual data entry errors. With AI-driven technologies enhancing the clinical trial process from patient identification to data management, TriaLinQ is revolutionizing the way trials are conducted. Request to download the factsheet to learn more about how TriaLinQ can benefit your practice: https://hubs.ly/Q02FdV0v0 #clinicaltrials #oncology #AI #digitalhealth #innovation.

Let's honor the strength and courage of cancer survivors. Their inspiring stories, resilience, and fight motivate us and our work. Show support by spreading awareness, sharing love, and standing by their side. To all survivors: you are heroes. Keep fighting, keep believing, and keep inspiring us with your unwavering strength.?

Day 2 of the 2024 AACI (Association of American Cancer Institutes) Meeting is here and we are thrilled to showcase how TraiLinQ? is revolutionizing the use of data to fill clinical trials. Visit us at table 3 to discover how our cutting-edge solutions are empowering oncologists to learn from every patient that they may reach every patient. #CRI2024 #TraiLinQ #ClinicalTrials #Oncology #Innovation